Rapport Therapeutics, Inc.
RAPP
$27.71
$0.592.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 96.98% | -8.74% | -6.52% | -4.80% | -4.60% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.31% | 9,590.00% | -66.67% | -66.67% | -30.77% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -98.09% | 29.94% | -3.56% | 35.67% |
| Total Current Assets | 92.66% | -7.12% | -6.08% | -4.95% | -4.32% |
|
|
|||||
| Total Current Assets | 92.66% | -7.12% | -6.08% | -4.95% | -4.32% |
| Net Property, Plant & Equipment | -4.38% | 30.76% | 118.75% | -0.90% | -4.33% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.29% | 390.05% | 31.88% | -15.34% | 0.00% |
| Total Assets | 87.51% | -5.48% | -4.09% | -4.90% | -4.32% |
|
|
|||||
| Total Accounts Payable | 1.86% | 48.48% | 9.47% | 47.69% | -29.44% |
| Total Accrued Expenses | 23.83% | 11.35% | 2.63% | 20.17% | -8.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 41.10% | 74.50% | 36.77% | 2.36% | 2.42% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.52% | 26.60% | 7.03% | 23.50% | -12.30% |
|
|
|||||
| Total Current Liabilities | 20.52% | 26.60% | 7.03% | 23.50% | -12.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.07% | 47.85% | 824.76% | -20.62% | -16.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.84% | 35.56% | 70.60% | 18.38% | -12.83% |
|
|
|||||
| Common Stock & APIC | 62.72% | 1.01% | 0.94% | 0.75% | 0.75% |
| Retained Earnings | -15.43% | -18.09% | -19.45% | -19.26% | -20.34% |
| Treasury Stock & Other | 290.79% | 20.00% | 81.80% | -230.50% | 318.58% |
| Total Common Equity | 94.15% | -7.81% | -6.41% | -5.47% | -4.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 94.15% | -7.81% | -6.41% | -5.47% | -4.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 94.15% | -7.81% | -6.41% | -5.47% | -4.09% |
|
|
|||||